Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

NIH 3OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Carcinoma 1

Interventions

Cisplatin 17Radiotherapy 11Cetuximab 11Surveys and Questionnaires 10pembrolizumab 9Biopsy 9Radiation 8Magnetic Resonance Spectroscopy 8Drug Therapy 8Surgical Procedures, Operative 7Radiotherapy, Intensity-Modulated 7Carboplatin 7X-Rays 6Specimen Handling 6Fluorouracil 6Celecoxib 6Standard of Care 5Paclitaxel 5Observation 5Sentinel Lymph Node Biopsy 4Interviews as Topic 4Chemoradiotherapy 41,2-diaminocyclohexaneplatinum II citrate 4Watchful Waiting 3Ultrasonography 3Taxes 3Practice Guidelines as Topic 3Positron Emission Tomography Computed Tomography 3Platinum 3Optical Imaging 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mouth Neoplasms × (225)Ac-DOTA-c(RGDyK) × Clear all
NCT07441681 2026-05-04

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

NRG Oncology

Phase 3 Not yet recruiting
454 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡